Literature DB >> 35758817

Do-calculus enables estimation of causal effects in partially observed biomolecular pathways.

Sara Mohammad-Taheri1, Jeremy Zucker2, Charles Tapley Hoyt3, Karen Sachs4,5, Vartika Tewari1, Robert Ness6, Olga Vitek1.   

Abstract

MOTIVATION: Estimating causal queries, such as changes in protein abundance in response to a perturbation, is a fundamental task in the analysis of biomolecular pathways. The estimation requires experimental measurements on the pathway components. However, in practice many pathway components are left unobserved (latent) because they are either unknown, or difficult to measure. Latent variable models (LVMs) are well-suited for such estimation. Unfortunately, LVM-based estimation of causal queries can be inaccurate when parameters of the latent variables are not uniquely identified, or when the number of latent variables is misspecified. This has limited the use of LVMs for causal inference in biomolecular pathways.
RESULTS: In this article, we propose a general and practical approach for LVM-based estimation of causal queries. We prove that, despite the challenges above, LVM-based estimators of causal queries are accurate if the queries are identifiable according to Pearl's do-calculus and describe an algorithm for its estimation. We illustrate the breadth and the practical utility of this approach for estimating causal queries in four synthetic and two experimental case studies, where structures of biomolecular pathways challenge the existing methods for causal query estimation.
AVAILABILITY AND IMPLEMENTATION: The code and the data documenting all the case studies are available at https://github.com/srtaheri/LVMwithDoCalculus. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35758817      PMCID: PMC9235495          DOI: 10.1093/bioinformatics/btac251

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.931


  17 in total

1.  Analysis of gene sets based on the underlying regulatory network.

Authors:  Ali Shojaie; George Michailidis
Journal:  J Comput Biol       Date:  2009-03       Impact factor: 1.479

Review 2.  Recent advances in modeling languages for pathway maps and computable biological networks.

Authors:  Ted Slater
Journal:  Drug Discov Today       Date:  2014-01-17       Impact factor: 7.851

3.  Computational model of EGFR and IGF1R pathways in lung cancer: a Systems Biology approach for Translational Oncology.

Authors:  Fortunato Bianconi; Elisa Baldelli; Vienna Ludovini; Lucio Crinò; Antonella Flacco; Paolo Valigi
Journal:  Biotechnol Adv       Date:  2011-05-18       Impact factor: 14.227

4.  Bayesian Inference for Integrating Yarrowia lipolytica Multiomics Datasets with Metabolic Modeling.

Authors:  Andrew D McNaughton; Erin L Bredeweg; James Manzer; Jeremy Zucker; Nathalie Munoz Munoz; Meagan C Burnet; Ernesto S Nakayasu; Kyle R Pomraning; Eric D Merkley; Ziyu Dai; William B Chrisler; Scott E Baker; Peter C St John; Neeraj Kumar
Journal:  ACS Synth Biol       Date:  2021-10-12       Impact factor: 5.110

5.  CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group.

Authors:  M D Hughes; M J Daniels; M A Fischl; S Kim; R T Schooley
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

6.  Reconstructing dynamic regulatory maps.

Authors:  Jason Ernst; Oded Vainas; Christopher T Harbison; Itamar Simon; Ziv Bar-Joseph
Journal:  Mol Syst Biol       Date:  2007-01-16       Impact factor: 11.429

7.  PyBEL: a computational framework for Biological Expression Language.

Authors:  Charles Tapley Hoyt; Andrej Konotopez; Christian Ebeling; Jonathan Wren
Journal:  Bioinformatics       Date:  2018-02-15       Impact factor: 6.937

8.  COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.

Authors:  Toshio Hirano; Masaaki Murakami
Journal:  Immunity       Date:  2020-04-22       Impact factor: 31.745

9.  Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.

Authors:  Chi Zhang; Zhao Wu; Jia-Wen Li; Hong Zhao; Gui-Qiang Wang
Journal:  Int J Antimicrob Agents       Date:  2020-03-29       Impact factor: 5.283

10.  The Escherichia coli transcriptome mostly consists of independently regulated modules.

Authors:  Anand V Sastry; Ye Gao; Richard Szubin; Ying Hefner; Sibei Xu; Donghyuk Kim; Kumari Sonal Choudhary; Laurence Yang; Zachary A King; Bernhard O Palsson
Journal:  Nat Commun       Date:  2019-12-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.